ANTAGONIST of Tumor necrosis factor receptor superfamily member 5 antagonist
Product Description
Lucatumumab (anti-CD40) is a fully human anti-CD40 antagonist monoclonal antibody, which blocks CD40/CD40L-mediated signaling. Lucatumumab (anti-CD40) efficiently mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and clearance of tumor cells, can be used for refractory lymphomas, CLL and multiple myeloma research. Purity >95% (SDS-PAGE&SEC) Endotoxin Level < 1.0EU/mg
Product Properties
Isotype
Human IgG1
Light Chain Type
kappa
SDS-PAGE
145 kDa
Purification Method
Protein A purified
Concentration
Lot by Lot
Storage Temp
Store at -80°C,Avoid repeated freezing and thawing
Shipped In
Ice chest + Ice pads
Stability And Storage
Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS
903512-50-5
Images
Lucatumumab (anti-CD40) (Ab183426) - Flow Cytometry Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD40 with Lucatumumab (anti-CD40) (Ab183426) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).
Lucatumumab (anti-CD40) (Ab183426) - Flow Cytometry Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD40 (red) with Lucatumumab (anti-CD40) (Ab183426) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.
Lucatumumab (anti-CD40) (Ab183426) - Flow Cytometry Flow Cytometry analysis of Raji cells labelling CD40 (red) with Lucatumumab (anti-CD40) (Ab183426). Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.
Lucatumumab (anti-CD40) (Ab183426) - ELISA Immobilized Recombinant Human CD40 protein (rp183577) at 1.0 μg/mL can bind Lucatumumab (anti-CD40) (Ab183426) with the EC₅₀ of 56.96 ng/mL.
Lucatumumab (anti-CD40) (Ab183426) - SEC The purity of Lucatumumab (anti-CD40) (Ab183426) is more than 95% verified by HPLC.
Associated Targets
CD40Tchem Tumor necrosis factor receptor superfamily member 5 0 Activities